U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C43H53NO9.2Na
Molecular Weight 773.8618
Optical Activity UNSPECIFIED
Defined Stereocenters 7 / 7
E/Z Centers 2
Charge 0

SHOW SMILES / InChI
Structure of S-0139

SMILES

[Na+].[Na+].[H][C@@]12CC(C)(C)CC[C@@]1(CC[C@]4(COC(=O)\C=C\C3=C(NC(=O)\C=C\C([O-])=O)C=CC(O)=C3)C2=CC[C@]5([H])[C@@]6(C)CCC(=O)C(C)(C)[C@]6([H])CC[C@@]45C)C([O-])=O

InChI

InChIKey=IFRVJMXGQTZXKQ-HECZARPRSA-L
InChI=1S/C43H55NO9.2Na/c1-38(2)19-20-42(37(51)52)21-22-43(25-53-36(50)14-7-26-23-27(45)8-10-30(26)44-34(47)12-13-35(48)49)28(29(42)24-38)9-11-32-40(5)17-16-33(46)39(3,4)31(40)15-18-41(32,43)6;;/h7-10,12-14,23,29,31-32,45H,11,15-22,24-25H2,1-6H3,(H,44,47)(H,48,49)(H,51,52);;/q;2*+1/p-2/b13-12+,14-7+;;/t29-,31-,32+,40-,41+,42-,43-;;/m0../s1

HIDE SMILES / InChI

Molecular Formula C43H53NO9
Molecular Weight 727.8822
Charge -2
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 7 / 7
E/Z Centers 2
Optical Activity UNSPECIFIED

Molecular Formula Na
Molecular Weight 22.9898
Charge 1
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Approval Year

Substance Class Chemical
Created
by admin
on Sat Dec 16 09:42:31 GMT 2023
Edited
by admin
on Sat Dec 16 09:42:31 GMT 2023
Record UNII
CXQ71T7YTY
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
S-0139
Code English
S 0139
Code English
OLEAN-12-EN-28-OIC ACID, 27-(((2E)-3-(2-(((2E)-3-CARBOXY-1-OXO-2-PROPENYL)AMINO)-5-HYDROXYPHENYL)-1-OXO-2-PROPENYL)OXY)-3-OXO-, SODIUM SALT (1:2)
Common Name English
737004
Code English
SB-737004
Code English
97-139
Code English
OLEAN-12-EN-28-OIC ACID, 27-((3-(2-((3-CARBOXY-1-OXO-2-PROPENYL)AMINO)-5-HYDROXYPHENYL)-1-OXO-2-PROPENYL)OXY)-3-OXO-, DISODIUM SALT, (27(E(E)))-
Systematic Name English
Code System Code Type Description
PUBCHEM
54687463
Created by admin on Sat Dec 16 09:42:31 GMT 2023 , Edited by admin on Sat Dec 16 09:42:31 GMT 2023
PRIMARY
MANUFACTURER PRODUCT INFORMATION
S-0139
Created by admin on Sat Dec 16 09:42:31 GMT 2023 , Edited by admin on Sat Dec 16 09:42:31 GMT 2023
PRIMARY Phase 1 Multicenter, Randomized, Double-Blind, Placebo Controlled, Single Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Response of PE0139 Injection in Adult Subjects With Type 2 Diabetes Mellitus
MANUFACTURER PRODUCT INFORMATION
SB-737004
Created by admin on Sat Dec 16 09:42:31 GMT 2023 , Edited by admin on Sat Dec 16 09:42:31 GMT 2023
PRIMARY
SMS_ID
300000042371
Created by admin on Sat Dec 16 09:42:31 GMT 2023 , Edited by admin on Sat Dec 16 09:42:31 GMT 2023
PRIMARY
CAS
162117-90-0
Created by admin on Sat Dec 16 09:42:31 GMT 2023 , Edited by admin on Sat Dec 16 09:42:31 GMT 2023
PRIMARY
FDA UNII
CXQ71T7YTY
Created by admin on Sat Dec 16 09:42:31 GMT 2023 , Edited by admin on Sat Dec 16 09:42:31 GMT 2023
PRIMARY
Related Record Type Details
PARENT -> SALT/SOLVATE
Related Record Type Details
ACTIVE MOIETY